Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Anti-infective Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Anti-infective Drug. This report contains market size and forecasts of Ophthalmic Anti-infective Drug in global, including the following market information:
Global Ophthalmic Anti-infective Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Ophthalmic Anti-infective Drug market was valued at US$ 1510.6 million in 2022 and is projected to reach US$ 1877.9 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
We surveyed the Ophthalmic Anti-infective Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Anti-infective Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, by Type, 2022 (%)
Eyedrops
Gels
Ointments
Other
Global Ophthalmic Anti-infective Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Ophthalmic Anti-infective Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Ophthalmic Anti-infective Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Anti-infective Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ophthalmic Anti-infective Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Anti-infective Drug, market overview.
Chapter 2: Global Ophthalmic Anti-infective Drug market size in revenue.
Chapter 3: Detailed analysis of Ophthalmic Anti-infective Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Anti-infective Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Anti-infective Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Anti-infective Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Anti-infective Drug Overall Market Size
2.1 Global Ophthalmic Anti-infective Drug Market Size: 2022 VS 2029
2.2 Global Ophthalmic Anti-infective Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ophthalmic Anti-infective Drug Players in Global Market
3.2 Top Global Ophthalmic Anti-infective Drug Companies Ranked by Revenue
3.3 Global Ophthalmic Anti-infective Drug Revenue by Companies
3.4 Top 3 and Top 5 Ophthalmic Anti-infective Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ophthalmic Anti-infective Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ophthalmic Anti-infective Drug Players in Global Market
3.6.1 List of Global Tier 1 Ophthalmic Anti-infective Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Ophthalmic Anti-infective Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ophthalmic Anti-infective Drug Market Size Markets, 2022 & 2029
4.1.2 Eyedrops
4.1.3 Gels
4.1.4 Ointments
4.1.5 Other
4.2 By Type - Global Ophthalmic Anti-infective Drug Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Anti-infective Drug Revenue, 2018-2023
4.2.2 By Type - Global Ophthalmic Anti-infective Drug Revenue, 2024-2029
4.2.3 By Type - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Anti-infective Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Ophthalmic Anti-infective Drug Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Anti-infective Drug Revenue, 2018-2023
5.2.2 By Application - Global Ophthalmic Anti-infective Drug Revenue, 2024-2029
5.2.3 By Application - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Ophthalmic Anti-infective Drug Market Size, 2022 & 2029
6.2 By Region - Global Ophthalmic Anti-infective Drug Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Anti-infective Drug Revenue, 2018-2023
6.2.2 By Region - Global Ophthalmic Anti-infective Drug Revenue, 2024-2029
6.2.3 By Region - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Ophthalmic Anti-infective Drug Revenue, 2018-2029
6.3.2 US Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.3.3 Canada Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.3.4 Mexico Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Ophthalmic Anti-infective Drug Revenue, 2018-2029
6.4.2 Germany Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.4.3 France Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.4.4 U.K. Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.4.5 Italy Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.4.6 Russia Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.4.7 Nordic Countries Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.4.8 Benelux Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Ophthalmic Anti-infective Drug Revenue, 2018-2029
6.5.2 China Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.5.3 Japan Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.5.4 South Korea Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.5.5 Southeast Asia Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.5.6 India Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Ophthalmic Anti-infective Drug Revenue, 2018-2029
6.6.2 Brazil Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.6.3 Argentina Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue, 2018-2029
6.7.2 Turkey Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.7.3 Israel Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Ophthalmic Anti-infective Drug Market Size, 2018-2029
6.7.5 UAE Ophthalmic Anti-infective Drug Market Size, 2018-2029
7 Ophthalmic Anti-infective Drug Companies Profiles
7.1 Alcon
7.1.1 Alcon Company Summary
7.1.2 Alcon Business Overview
7.1.3 Alcon Ophthalmic Anti-infective Drug Major Product Offerings
7.1.4 Alcon Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.1.5 Alcon Key News & Latest Developments
7.2 AbbVie
7.2.1 AbbVie Company Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Ophthalmic Anti-infective Drug Major Product Offerings
7.2.4 AbbVie Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.2.5 AbbVie Key News & Latest Developments
7.3 Bausch Health
7.3.1 Bausch Health Company Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Ophthalmic Anti-infective Drug Major Product Offerings
7.3.4 Bausch Health Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.3.5 Bausch Health Key News & Latest Developments
7.4 Santen Pharmaceutical
7.4.1 Santen Pharmaceutical Company Summary
7.4.2 Santen Pharmaceutical Business Overview
7.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Major Product Offerings
7.4.4 Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.4.5 Santen Pharmaceutical Key News & Latest Developments
7.5 Lupin Pharmaceuticals
7.5.1 Lupin Pharmaceuticals Company Summary
7.5.2 Lupin Pharmaceuticals Business Overview
7.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Major Product Offerings
7.5.4 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.5.5 Lupin Pharmaceuticals Key News & Latest Developments
7.6 Apotex
7.6.1 Apotex Company Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Ophthalmic Anti-infective Drug Major Product Offerings
7.6.4 Apotex Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.6.5 Apotex Key News & Latest Developments
7.7 Akorn
7.7.1 Akorn Company Summary
7.7.2 Akorn Business Overview
7.7.3 Akorn Ophthalmic Anti-infective Drug Major Product Offerings
7.7.4 Akorn Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.7.5 Akorn Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Major Product Offerings
7.8.4 Johnson & Johnson Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Thea pharmaceuticals
7.9.1 Thea pharmaceuticals Company Summary
7.9.2 Thea pharmaceuticals Business Overview
7.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Major Product Offerings
7.9.4 Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.9.5 Thea pharmaceuticals Key News & Latest Developments
7.10 URSAPHARM
7.10.1 URSAPHARM Company Summary
7.10.2 URSAPHARM Business Overview
7.10.3 URSAPHARM Ophthalmic Anti-infective Drug Major Product Offerings
7.10.4 URSAPHARM Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.10.5 URSAPHARM Key News & Latest Developments
7.11 SIMILASAN
7.11.1 SIMILASAN Company Summary
7.11.2 SIMILASAN Business Overview
7.11.3 SIMILASAN Ophthalmic Anti-infective Drug Major Product Offerings
7.11.4 SIMILASAN Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.11.5 SIMILASAN Key News & Latest Developments
7.12 Jianfeng Group
7.12.1 Jianfeng Group Company Summary
7.12.2 Jianfeng Group Business Overview
7.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Major Product Offerings
7.12.4 Jianfeng Group Ophthalmic Anti-infective Drug Revenue in Global Market (2018-2023)
7.12.5 Jianfeng Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ophthalmic Anti-infective Drug Market Opportunities & Trends in Global Market
Table 2. Ophthalmic Anti-infective Drug Market Drivers in Global Market
Table 3. Ophthalmic Anti-infective Drug Market Restraints in Global Market
Table 4. Key Players of Ophthalmic Anti-infective Drug in Global Market
Table 5. Top Ophthalmic Anti-infective Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ophthalmic Anti-infective Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ophthalmic Anti-infective Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ophthalmic Anti-infective Drug Product Type
Table 9. List of Global Tier 1 Ophthalmic Anti-infective Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Anti-infective Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ophthalmic Anti-infective Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Ophthalmic Anti-infective Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ophthalmic Anti-infective Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2024-2029
Table 30. Alcon Company Summary
Table 31. Alcon Ophthalmic Anti-infective Drug Product Offerings
Table 32. Alcon Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Alcon Key News & Latest Developments
Table 34. AbbVie Company Summary
Table 35. AbbVie Ophthalmic Anti-infective Drug Product Offerings
Table 36. AbbVie Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 37. AbbVie Key News & Latest Developments
Table 38. Bausch Health Company Summary
Table 39. Bausch Health Ophthalmic Anti-infective Drug Product Offerings
Table 40. Bausch Health Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bausch Health Key News & Latest Developments
Table 42. Santen Pharmaceutical Company Summary
Table 43. Santen Pharmaceutical Ophthalmic Anti-infective Drug Product Offerings
Table 44. Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Santen Pharmaceutical Key News & Latest Developments
Table 46. Lupin Pharmaceuticals Company Summary
Table 47. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product Offerings
Table 48. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Lupin Pharmaceuticals Key News & Latest Developments
Table 50. Apotex Company Summary
Table 51. Apotex Ophthalmic Anti-infective Drug Product Offerings
Table 52. Apotex Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Apotex Key News & Latest Developments
Table 54. Akorn Company Summary
Table 55. Akorn Ophthalmic Anti-infective Drug Product Offerings
Table 56. Akorn Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Akorn Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Ophthalmic Anti-infective Drug Product Offerings
Table 60. Johnson & Johnson Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Thea pharmaceuticals Company Summary
Table 63. Thea pharmaceuticals Ophthalmic Anti-infective Drug Product Offerings
Table 64. Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Thea pharmaceuticals Key News & Latest Developments
Table 66. URSAPHARM Company Summary
Table 67. URSAPHARM Ophthalmic Anti-infective Drug Product Offerings
Table 68. URSAPHARM Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 69. URSAPHARM Key News & Latest Developments
Table 70. SIMILASAN Company Summary
Table 71. SIMILASAN Ophthalmic Anti-infective Drug Product Offerings
Table 72. SIMILASAN Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 73. SIMILASAN Key News & Latest Developments
Table 74. Jianfeng Group Company Summary
Table 75. Jianfeng Group Ophthalmic Anti-infective Drug Product Offerings
Table 76. Jianfeng Group Ophthalmic Anti-infective Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Jianfeng Group Key News & Latest Developments
List of Figures
Figure 1. Ophthalmic Anti-infective Drug Segment by Type in 2022
Figure 2. Ophthalmic Anti-infective Drug Segment by Application in 2022
Figure 3. Global Ophthalmic Anti-infective Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Anti-infective Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ophthalmic Anti-infective Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ophthalmic Anti-infective Drug Revenue in 2022
Figure 8. By Type - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 16. US Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 20. Germany Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 28. China Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Ophthalmic Anti-infective Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Ophthalmic Anti-infective Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Alcon Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AbbVie Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bausch Health Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Apotex Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Akorn Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. URSAPHARM Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. SIMILASAN Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jianfeng Group Ophthalmic Anti-infective Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
